Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer

Yuko Matsubara; Keiichiro Nakamura; Hirofumi Matsuoka; Chikako Ogawa; Hisashi Masuyama

doi:10.3892/mco.2019.1912

Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer

Yuko Matsubara, Keiichiro Nakamura, Hirofumi Matsuoka, Chikako Ogawa, Hisashi Masuyama

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Low skeletal muscle mass (sarcopenia) is an important prognostic risk factor for the outcome of a variety of cancer types. The current study investigated whether skeletal muscle area (SMA), psoas area (PA) and psoas major volume (PV) are associated with progression-free survival (PFS) and overall survival (OS) in patients with epithelial ovarian cancer (OC). A total of 92 OC patients were enrolled in the present study. Pre-treatment with SMA and PA was assessed using computed tomography (CT) and PV was calculated using a three-dimensional-CT (3D-CT). The clinical factors associated with sarcopenia and prognosis were retrospectively evaluated. For all patients, the median PFS and OS were 19 and 32 months, respectively. Patients exhibiting lower PV (<195.6 cm3) had significantly poorer PFS and OS compared with patients exhibiting higher PV (≥195.6 cm3; P=0.018 and P=0.006), while those with low SMA (<92.92 cm2) had significantly worse OS than patients with higher SMA (≥92.92 cm2; P=0.030). PV was also demonstrated to be superior to SMA and PA in prognosis prediction. PV by 3D-CT can serve as an indicator of poor prognosis in patients with OC.

Original language	English
Pages (from-to)	376-382
Number of pages	7
Journal	Molecular and Clinical Oncology
Volume	11
Issue number	4
DOIs	https://doi.org/10.3892/mco.2019.1912
Publication status	Published - Oct 2019

Keywords

Low skeletal muscle mass
Ovarian cancer
Prognostic factor
Psoas area
Psoas major volume
Skeletal muscle area

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.3892/mco.2019.1912

Fingerprint Dive into the research topics of 'Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer'. Together they form a unique fingerprint.

Cite this

@article{0cf0941d37284006a1023659d1caa8f0,

title = "Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer",

abstract = "Low skeletal muscle mass (sarcopenia) is an important prognostic risk factor for the outcome of a variety of cancer types. The current study investigated whether skeletal muscle area (SMA), psoas area (PA) and psoas major volume (PV) are associated with progression-free survival (PFS) and overall survival (OS) in patients with epithelial ovarian cancer (OC). A total of 92 OC patients were enrolled in the present study. Pre-treatment with SMA and PA was assessed using computed tomography (CT) and PV was calculated using a three-dimensional-CT (3D-CT). The clinical factors associated with sarcopenia and prognosis were retrospectively evaluated. For all patients, the median PFS and OS were 19 and 32 months, respectively. Patients exhibiting lower PV (<195.6 cm3) had significantly poorer PFS and OS compared with patients exhibiting higher PV (≥195.6 cm3; P=0.018 and P=0.006), while those with low SMA (<92.92 cm2) had significantly worse OS than patients with higher SMA (≥92.92 cm2; P=0.030). PV was also demonstrated to be superior to SMA and PA in prognosis prediction. PV by 3D-CT can serve as an indicator of poor prognosis in patients with OC.",

keywords = "Low skeletal muscle mass, Ovarian cancer, Prognostic factor, Psoas area, Psoas major volume, Skeletal muscle area",

author = "Yuko Matsubara and Keiichiro Nakamura and Hirofumi Matsuoka and Chikako Ogawa and Hisashi Masuyama",

year = "2019",

month = oct,

doi = "10.3892/mco.2019.1912",

language = "English",

volume = "11",

pages = "376--382",

journal = "Molecular and Clinical Oncology",

issn = "2049-9450",

publisher = "Spandidos Publications UK",

number = "4",

}

TY - JOUR

T1 - Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer

AU - Matsubara, Yuko

AU - Nakamura, Keiichiro

AU - Matsuoka, Hirofumi

AU - Ogawa, Chikako

AU - Masuyama, Hisashi

PY - 2019/10

Y1 - 2019/10

N2 - Low skeletal muscle mass (sarcopenia) is an important prognostic risk factor for the outcome of a variety of cancer types. The current study investigated whether skeletal muscle area (SMA), psoas area (PA) and psoas major volume (PV) are associated with progression-free survival (PFS) and overall survival (OS) in patients with epithelial ovarian cancer (OC). A total of 92 OC patients were enrolled in the present study. Pre-treatment with SMA and PA was assessed using computed tomography (CT) and PV was calculated using a three-dimensional-CT (3D-CT). The clinical factors associated with sarcopenia and prognosis were retrospectively evaluated. For all patients, the median PFS and OS were 19 and 32 months, respectively. Patients exhibiting lower PV (<195.6 cm3) had significantly poorer PFS and OS compared with patients exhibiting higher PV (≥195.6 cm3; P=0.018 and P=0.006), while those with low SMA (<92.92 cm2) had significantly worse OS than patients with higher SMA (≥92.92 cm2; P=0.030). PV was also demonstrated to be superior to SMA and PA in prognosis prediction. PV by 3D-CT can serve as an indicator of poor prognosis in patients with OC.

AB - Low skeletal muscle mass (sarcopenia) is an important prognostic risk factor for the outcome of a variety of cancer types. The current study investigated whether skeletal muscle area (SMA), psoas area (PA) and psoas major volume (PV) are associated with progression-free survival (PFS) and overall survival (OS) in patients with epithelial ovarian cancer (OC). A total of 92 OC patients were enrolled in the present study. Pre-treatment with SMA and PA was assessed using computed tomography (CT) and PV was calculated using a three-dimensional-CT (3D-CT). The clinical factors associated with sarcopenia and prognosis were retrospectively evaluated. For all patients, the median PFS and OS were 19 and 32 months, respectively. Patients exhibiting lower PV (<195.6 cm3) had significantly poorer PFS and OS compared with patients exhibiting higher PV (≥195.6 cm3; P=0.018 and P=0.006), while those with low SMA (<92.92 cm2) had significantly worse OS than patients with higher SMA (≥92.92 cm2; P=0.030). PV was also demonstrated to be superior to SMA and PA in prognosis prediction. PV by 3D-CT can serve as an indicator of poor prognosis in patients with OC.

KW - Low skeletal muscle mass

KW - Ovarian cancer

KW - Prognostic factor

KW - Psoas area

KW - Psoas major volume

KW - Skeletal muscle area

UR - http://www.scopus.com/inward/record.url?scp=85073392966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073392966&partnerID=8YFLogxK

U2 - 10.3892/mco.2019.1912

DO - 10.3892/mco.2019.1912

M3 - Article

AN - SCOPUS:85073392966

VL - 11

SP - 376

EP - 382

JO - Molecular and Clinical Oncology

JF - Molecular and Clinical Oncology

SN - 2049-9450

IS - 4

ER -

Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this